Clinical role of 18F-FDG PET/CT in the management of squamous cell carcinoma of the head and neck and thyroid carcinoma.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 17204721.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
18F-FDG PET/CT has rapidly become a widely used imaging modality for evaluating a variety of malignancies, including squamous cell carcinoma of the head and neck and thyroid cancer. Using both published data and the multidisciplinary experience at our institution, we provide a practical set of guidelines and algorithms for the use of 18F-FDG PET/CT in the evaluation and management of head and neck cancer and thyroid cancer.
Medical subject headings
- Carcinoma, Squamous Cell
- Fluorodeoxyglucose F18
- Head and Neck Neoplasms
- Positron-Emission Tomography
- Thyroid Neoplasms
- Tomography, X-Ray Computed
- Whole Body Imaging